Results 21 to 30 of about 1,585,150 (380)

Predictive Values of Serum IL-33 and sST2 in Endotypes and Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps

open access: yesMediators of Inflammation, 2022
Background. Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common inflammatory disease with high heterogeneity and postoperative recidivation. The IL-33/ST2 axis is known to be involved in Th2 immune responses.
Yanni Zhang   +8 more
doaj   +1 more source

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

open access: yesNew England Journal of Medicine, 2006
BACKGROUND We conducted a multinational, randomized study to compare radiotherapy alone with radiotherapy plus cetuximab, a monoclonal antibody against the epidermal growth factor receptor, in the treatment of locoregionally advanced squamous-cell ...
J. Bonner   +17 more
semanticscholar   +1 more source

Transnasal Endoscopic Orbital Decompression Combined with an Enhanced Recovery after Surgery Protocol in Graves Ophthalmopathy

open access: yesJournal of Ophthalmology, 2022
Objective. Although enhanced recovery after surgery (ERAS) was shown to improve patients’ recovery after surgery and transnasal endoscopic orbital decompression has been associated with lesser risks of postoperative complications compared to other ...
Hui-Qing Xu   +4 more
doaj   +1 more source

Comprehensive genomic characterization of head and neck squamous cell carcinomas

open access: yesNature, 2015
The Cancer Genome Atlas profiled 279 head and neck squamous cell carcinomas (HNSCCs) to provide a comprehensive landscape of somatic genomic alterations.
M. Lawrence   +309 more
semanticscholar   +1 more source

A practical approach to the patient presenting with dropped head [PDF]

open access: yes, 2016
Head drop, or having a dropped head, is an uncommon condition in which patients present with a disabling inability to lift their head. It may arise in many neurological conditions that can be divided into those with neuromuscular weakness of neck ...
Demicoli, Marija, Marsh, Eleanor A.
core   +1 more source

Exploration of Predictive Biomarkers for Postoperative Recurrence in Chronic Rhinosinusitis with Nasal Polyps Based on Serum Multiple-Cytokine Profiling

open access: yesMediators of Inflammation, 2022
Background. Functional nasal endoscopic surgery (FESS) is an effective treatment approach for chronic rhinosinusitis with nasal polyps (CRSwNP) patients, but some patients still suffer from postoperative recurrence.
Gang Wang   +9 more
doaj   +1 more source

Evaluation of a pig femoral head osteonecrosis model [PDF]

open access: yes, 2010
Background A major cause of osteonecrosis of the femoral head is interruption of a blood supply to the proximal femur. In order to evaluate blood circulation and pathogenetic alterations, a pig femoral head osteonecrosis model was examined to address ...
Kim, Harry   +3 more
core   +2 more sources

The impact of Coronavirus (COVID-19) on head and neck cancer patients' care [PDF]

open access: yes, 2020
The impact of Coronavirus (COVID-19) on head and neck cancer patients ...
De Felice, Francesca   +2 more
core   +1 more source

Circulating MMP-12 as Potential Biomarker in Evaluating Disease Severity and Efficacy of Sublingual Immunotherapy in Allergic Rhinitis

open access: yesMediators of Inflammation, 2022
Background. Allergic rhinitis (AR) is a highly heterogeneous disease, and allergen-specific immunotherapy (AIT) is an effective treatment. This study aims to evaluate the circulating mas-related G protein-coupled receptor-X2 (MRGPRX2) and matrix ...
Yandan Zhou   +9 more
doaj   +1 more source

Platinum-based chemotherapy plus cetuximab in head and neck cancer.

open access: yesNew England Journal of Medicine, 2008
BACKGROUND Cetuximab is effective in platinum-resistant recurrent or metastatic squamous-cell carcinoma of the head and neck. We investigated the efficacy of cetuximab plus platinum-based chemotherapy as first-line treatment in patients with recurrent or
J. Vermorken   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy